{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/GRAL/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-09T09:52:33.622Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9488,"canonical_name":"GRAIL, Inc.","cik":"0001699031","uei":null,"lei":null,"duns":null,"ticker":"GRAL"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":20,"clinical":2},"count":22,"timeline":[{"ts":"2026-07-16","kind":"sec.filing","form_type":"4","title":"4 — SUMME GREGORY L — 2026-07-16","url_slug":"/sec/cik-0001143422/4/0001628280-26-048487","accession_number":"0001628280-26-048487","importance":30},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"SUMME GREGORY L","title":null,"shares":427,"price_per_share":74.36,"usd_value":31752,"security_title":"Common Stock","importance":15.03175172},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"CHASE WILLIAM J","title":null,"shares":276,"price_per_share":74.36,"usd_value":20523,"security_title":"Common Stock","importance":15.02052336},{"ts":"2026-07-15","kind":"sec.insider.a","reporter":"MIZELL STEVEN","title":null,"shares":268,"price_per_share":74.36,"usd_value":19928,"security_title":"Common Stock","importance":15.01992848},{"ts":"2026-06-22","kind":"sec.filing","form_type":"8-K","title":"8-K — GRAIL, Inc. — 2026-06-22","url_slug":"/sec/cik-0001699031/8-k/0001628280-26-044693","accession_number":"0001628280-26-044693","importance":35},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — SUMME GREGORY L — 2026-06-22","url_slug":"/sec/cik-0001143422/4/0001628280-26-044734","accession_number":"0001628280-26-044734","importance":30},{"ts":"2026-06-22","kind":"sec.filing","form_type":"4","title":"4 — GRAIL, Inc. — 2026-06-22","url_slug":"/sec/cik-0001699031/4/0001628280-26-044733","accession_number":"0001628280-26-044733","importance":30},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"SUMME GREGORY L","title":null,"shares":5491,"price_per_share":63.74,"usd_value":349996,"security_title":"Common Stock","importance":15.34999634},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"MIZELL STEVEN","title":null,"shares":5491,"price_per_share":63.74,"usd_value":349996,"security_title":"Common Stock","importance":15.34999634},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"CHASE WILLIAM J","title":null,"shares":5491,"price_per_share":63.74,"usd_value":349996,"security_title":"Common Stock","importance":15.34999634},{"ts":"2026-06-18","kind":"sec.insider.a","reporter":"Krevans Sarah","title":null,"shares":5491,"price_per_share":63.74,"usd_value":349996,"security_title":"Common Stock","importance":15.34999634},{"ts":"2026-06-05","kind":"sec.filing","form_type":"4","title":"4 — GRAIL, Inc. — 2026-06-05","url_slug":"/sec/cik-0001699031/4/0001628280-26-041356","accession_number":"0001628280-26-041356","importance":30},{"ts":"2026-06-04","kind":"sec.insider.s","reporter":"Partridge Andrew John","title":"Chief Growth Officer","shares":1491,"price_per_share":61.08,"usd_value":91070,"security_title":"Common Stock","importance":35.09107028},{"ts":"2026-06-03","kind":"sec.form144","reporter":"Andrew Partridge","title":"Officer","shares":1705,"usd_value":104227,"security_title":"Common Stock","approx_sale_date":"2026-06-03","accession_number":"0001628280-26-040564","importance":40.02084533},{"ts":"2026-06-03","kind":"sec.filing","form_type":"144","title":"144 — GRAIL, Inc. — 2026-06-03","url_slug":"/sec/cik-0001699031/144/0001628280-26-040564","accession_number":"0001628280-26-040564","importance":30},{"ts":"2026-06-03","kind":"sec.filing","form_type":"4","title":"4 — GRAIL, Inc. — 2026-06-03","url_slug":"/sec/cik-0001699031/4/0001628280-26-040590","accession_number":"0001628280-26-040590","importance":30},{"ts":"2026-06-03","kind":"sec.insider.a","reporter":"Ofman Joshua J.","title":"Chief Executive Officer","shares":3154,"price_per_share":61.13,"usd_value":192804,"security_title":"Common Stock","importance":15.19280402},{"ts":"2026-06-02","kind":"sec.filing","form_type":"3","title":"3 — GRAIL, Inc. — 2026-06-02","url_slug":"/sec/cik-0001699031/3/0001628280-26-039952","accession_number":"0001628280-26-039952","importance":30},{"ts":"2026-06-01","kind":"sec.filing","form_type":"8-K","title":"8-K — GRAIL, Inc. — 2026-06-01","url_slug":"/sec/cik-0001699031/8-k/0001628280-26-039461","accession_number":"0001628280-26-039461","importance":35},{"ts":"2026-06-01","kind":"sec.insider.a","reporter":"Ofman Joshua J.","title":"Chief Executive Officer","shares":27901,"price_per_share":64.4,"usd_value":1796824,"security_title":"Common Stock","importance":16.7968244},{"ts":"2026-05-14","kind":"clinical.trial","reporter":"GRAIL, Inc.","title":"PATHFINDER 2: A Multi-Cancer Early Detection Study","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05155605","excerpt":"[\"Early Detection of Cancer\",\"Cancer\"]","importance":25},{"ts":"2026-04-14","kind":"clinical.trial","reporter":"GRAIL, Inc.","title":"Does Screening With the Galleri Test in the NHS Reduce the Likelihood of a Late-stage Cancer Diagnosis in an Asymptomatic Population? A Randomised Clinical Trial","security_title":"NA","status":"ACTIVE_NOT_RECRUITING","accession_number":"NCT05611632","excerpt":"[\"Cancer\"]","importance":25}]}